Form 4: Tandem Diabetes Care EVP Leigh Vosseller Reports Stock Transactions
SEC Form 4
Leigh Vosseller, EVP & CFO of Tandem Diabetes Care, reports the vesting and tax-related withholding of restricted stock units.
Summary
- Leigh Vosseller, the EVP & CFO of Tandem Diabetes Care, filed a Form 4 on February 20, 2025, reporting transactions that occurred on February 18, 2025.
- The transactions involved the vesting of restricted stock units (RSUs) and the subsequent withholding of shares to cover tax obligations.
- Vosseller acquired 163, 474, and 1,504 shares of common stock through the vesting of RSUs at a price of $0.
- Simultaneously, 67, 195, and 618 shares were disposed of to satisfy tax withholding requirements at a price of $33.47 per share.
- Following these transactions, Vosseller directly owns 22,843 shares of common stock and indirectly owns 11,860 shares through the Leigh A. Vosseller Trust.
- She also directly owns 162, 474, and 7,515 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't convey any particularly positive or negative sentiment about the company's performance or prospects.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It doesn't necessarily indicate a broader trend in the diabetes care industry.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules and tax withholding practices described in the filing are typical for RSU grants.
- Comparable companies such as Insulet (PODD) and Dexcom (DXCM) also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they involve the vesting of previously granted equity compensation.
- Employees holding RSUs may be affected by the tax implications of vesting.
Key Dates
| Date | Description |
|---|---|
| January 17, 2010 | Date of the Leigh A. Vosseller Trust. |
| May 18, 2021 | Date of RSU award pursuant to the 2013 Stock Incentive Plan. |
| May 15, 2022 | First vesting date (25%) for RSU awarded on May 18, 2021. |
| May 25, 2022 | Date of RSU award pursuant to the 2013 Stock Incentive Plan. |
| May 15, 2023 | First vesting date (33%) for RSU awarded on May 25, 2022. |
| May 25, 2023 | Date of RSU award pursuant to the 2023 Long-Term Incentive Plan. |
| May 15, 2024 | First vesting date (33%) for RSU awarded on May 25, 2023. |
| February 18, 2025 | Date of reported transactions (RSU vesting and tax withholding). |
| February 20, 2025 | Date Form 4 was filed. |
Keywords
Form 4, Tandem Diabetes Care, Vosseller, Restricted Stock Units, Stock Transactions, Beneficial Ownership, Tax Withholding, TNDM
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.